FdaApplication
ANDA 212623
Identifiers
- fda_app_no: ANDA212623
Properties
| Property | Value |
|---|---|
| applicant_name | POINTVIEW HOLDINGS LLC |
| application_type | ANDA |
| approval_date | 2021-04-30 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METHOCARBAMOL | METHOCARBAMOL | 750MG | TABLET;ORAL |
| METHOCARBAMOL | METHOCARBAMOL | 500MG | TABLET;ORAL |
2 products